Results 21 to 30 of about 4,582,351 (335)

Self-regulated hirudin delivery for anticoagulant therapy

Science Advances, 2020
Polymeric nanogel with on-demand release of hirudin prevents and inhibits clot formation. Pathological coagulation, a disorder of blood clotting regulation, induces a number of cardiovascular diseases.
Xiao Xu, Xuechao Huang, Ying Zhang, Shiyang Shen, Zhizi Feng, He Dong, Can Zhang, Ran Mo   +7 more
semanticscholar   +1 more source

Impact of Preinjury Antithrombotic Therapy on 30–Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)

Frontiers in Neurology, 2021
Objective: Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear.Methods: This ...
Pål Rønning, Eirik Helseth, Eirik Helseth, Ola Skaansar, Cathrine Tverdal, Cathrine Tverdal, Nada Andelic, Nada Andelic, Rahul Bhatnagar, Mathias Melberg, Nils Oddvar Skaga, Mads Aarhus, Sigrun Halvorsen, Sigrun Halvorsen, Ragnhild Helseth   +14 more
doaj   +1 more source

Anticoagulant therapy for splanchnic vein thrombosis

Journal of Thrombosis and Haemostasis, 2020
1Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands 2Department of Medicine and Ageing Sciences, “G. D'Annunzio” University, Chieti-Pescara, Italy 3Department of Medical, Oral and Biotechnological Sciences, “G.
M. Di Nisio, Emanuele Valeriani, Nicoletta Riva, S. Schulman, J. Beyer-Westendorf, W. Ageno   +5 more
semanticscholar   +1 more source

Factors influencing primary care physicians’ prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study

BMC Family Practice, 2021
Background Oral anticoagulant therapy use in patients with atrial fibrillation (AF) remains suboptimal in Singapore, despite the availability of both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs).
Shera Chaterji, Lay Geok Lian, Ting Yee Lee, Liwei Chua, Sabrina Yi-Mei Wee, Sui Ling Yap, Dhana Letchimy K, Ngiap Chuan Tan   +7 more
doaj   +1 more source

Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

Mutiara Medika, 2022
Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis.
Agus Fitriyanto Achmad, Yuni Iswati Raharjani, Zidni Setyaningrum, Bagus Andi Pramono, Dita Ria Selvyana, Sri Pramesthi Wisnu Bowo Negoro   +5 more
doaj   +1 more source

Clinical audit of anticoagulant therapy with pregnancy

Al-Azhar Assiut Medical Journal, 2020
Background and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy ...
Mahmoud I El-Rasheedy, Ahmed H Mohammed, Asmaa M Mahmoud   +2 more
doaj   +1 more source

Future of Anticoagulant Therapy [PDF]

Cardiovascular Therapeutics, 2010
Prophylaxis and treatment of thromboembolic diseases is one of the main targets in medicine. Side effects and the necessity of dose adjustment limit the administration of coumarins and unfractionated heparin. Coumarins are therefore underused specially in the elderly population. Low-molecular-weight heparins, heparinoids, and direct thrombin inhibitors
Job Harenberg, Martin Wehling
openaire   +3 more sources

Does antithrombotic therapy improve survival with colorectal cancer?

World Journal of Surgical Oncology, 2017
Background The study aimed to evaluate the prognosis for patients with colorectal cancer who underwent surgery while receiving antithrombotic therapy (ATT) across all disease stages and for patients at disease stages 0–III.
Kodai Takahashi, Hideto Ito, Masatoshi Hashimoto, Kazuhito Mita, Hideki Asakawa, Takashi Hayashi, Keiichi Fujino   +6 more
doaj   +1 more source

Anticoagulation Therapy

Hematology, 2001
Abstract Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding ...
J A, Ginsberg, M A, Crowther, R H, White, T L, Ortel   +3 more
openaire   +2 more sources

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice

Рациональная фармакотерапия в кардиологии, 2020
Aim. To study the frequency of prescribing anticoagulant therapy in outpatients with AF in accordance with clinical guidelines.Material and methods. Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF) observational study was conducted at ...
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko   +2 more
doaj   +1 more source